BAMF Health
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study) (NCT05823402) | BAMF Health | 2023-05-01 |
| Total Body PET-CT Imaging of Prostate Cancer Using Illuccix (NCT05558956) | BAMF Health | 2022-11-01 |
Track BAMF Health automatically
Every clearance here is in the API, with alerts when new ones post.